Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development
Tempus AI Inc Class A common stock TEM
News
Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
Tempus Announces Real World Data Collaboration with BioNTech
Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay
Tempus Reports Second Quarter 2024 Results
Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2
Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics
Tempus to Report Second Quarter 2024 Financial Results on August 6
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests
Tempus Surpasses 500 Research Publications
Buy this healthcare company's stock because it's an AI play, analysts say
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM
SoftBank Group to Form Joint Venture With U.S. Healthcare Firm Tempus AI
Tempus AI Gets 510(k) Clearance for ECG-AF Device
United States